Status | Study |
Completed |
Study Name: REal World EVidence for TrEAtment of HyperkaLemia in Emergency Department: Multicenter, Prospective, Observational Study Condition: Hyperkalemia Date: 2015-11-13 |
Completed |
Study Name: Open-label Safety and Efficacy of Sodium Zirconium Cyclosilicate for up to 12 Months Condition: Hyperkalemia Date: 2014-06-11 Interventions: Drug: Sodium Zirconium Cyclosilicate Acute Phase Dosing: Sodium Zirconium Cyclosilicate 10 g three times |
Completed |
Study Name: Open-label Safety & Efficacy of ZS (Sodium Zirconium Cyclosilicate)10g qd to Extend Study ZS-004 in Hyperkalemia. Condition: Hyperkalemia Date: 2014-04-03 Interventions: Drug: Sodium Zirconium Cyclosilicate Oral 10g once daily with breakfast for 11 months. |
Completed |
Study Name: Safety & Efficacy of Zirconium Silicate Dosed for 28 Days in Hyperkalemia. Condition: Hyperkalemia Date: 2014-03-12 Interventions: Drug: Zirconium silicate (acute phase) |
Completed |
Study Name: Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients Condition: Hyperkalemia Chronic Kidney Failure Date: 2014-02-14 Interventions: Drug: Sodium polystyrene sulfonate |
Terminated |
Study Name: An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis Condition: Hyperkalemia Date: 2014-01-09 Interventions: Drug: patiromer 15 grams/day (5 grams 3 times daily) administered orally |
Completed |
Study Name: Clinical Decision Support System for Quality Assurance in Potassium-Increasing Drug-Drug-Interactions Condition: Hyperkalemia Date: 2013-12-12 Interventions: Behavioral: decision support in potassium-inc. drug-drug-interactions display of computer-based reminder |
Terminated |
Study Name: Safety and Efficacy of Sodium Polystyrene Sulfonate in Hyperkalemia Condition: Hyperkalemia Date: 2013-05-28 Interventions: Drug: Sodium polystyrene sulfonate |
Completed |
Study Name: A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL) Condition: Chronic Kidney Disease (CKD) Hyperkalemia (HK) Date: 2013-03-12 Interventions: Drug: Patiromer Other Names: |
Completed |
Study Name: Safety & Efficacy of Zirconium Silicate in Mild to Moderate Hyperkalemia Condition: Hyperkalemia Date: 2012-11-19 Interventions: Drug: Zirconium silicate (acute phase) |